In Vitro Activity of ACHN-490 Tested Against Gram-Negative and Gram-Positive Pathogens Isolated from Patients in Canadian Hospitals in 2011: CANWARD Surveillance Study

GG Zhanel, J Karlowsky, H Adam, M Baxter, A Walkty, PRS Lagacé-Wiens, F Schweizer, DJ Hoban
University of Manitoba, Health Sciences Centre, St. Boniface Hospital, Winnipeg, Canada
IDSA 2011, poster # 597

Download poster as PDF 

Activity of ACHN-490 against meticillin-resistant Staphylococcus aureus (MRSA) isolates from patients in US hospitals

Tenover, FC; Tickler, I; Armstrong, ES; Kubo, A; Lopez, S; Persing, DH; Miller, GH
International journal of antimicrobial agents 2011;38(4):352-4.

Access this publication @ sciencedirect.com (purchase or paid subscription required)

 

Activity of ACHN-490 against MDR clinical isolates of Klebsiella pneumoniae, Escherichia coli and Enterobacter spp. from Athens, Greece

I. Galani, M. Souli, G. Daikos, Z. Chrysouli, G. Poulakou, M. Psichogiou, T. Panayea, A. Argyropoulou , I. Stefanou, G. Plakias, H. Giamarellou, G. Petrikkos
4th Dept Internal Medicine, Athens Medical School, Attikon University General Hospital
ECCMID 2011, poster # P1147
 

 Download poster as PDF